Position in EOLS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$229,580
-$8,882 QoQ
Shares Held
55,859
+55.8% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ADAR1 Capital Management, LLC holds $31,391,903 across 13 Drug Manufacturers - Specialty & Generic names. EOLS ranks #11 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
1,000,604 | $13,908,395 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
268,391 | $8,083,936 | |
| 3 | BIOA |
BioAge Labs, Inc.
|
135,560 | $2,370,944 | |
| 4 | ALKS |
Alkermes plc.
|
46,400 | $1,640,704 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
29,642 | $1,532,194 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
26,913 | $1,295,860 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
105,000 | $999,600 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
20,000 | $478,600 |
All Filings in EOLS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $229,580 | 55,859 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $238,462 | 35,859 | Shares | Sole | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||